Here's what happened this week in investing & stock news!

Check out the top 5 market highlights featured on Investors.com...

Why Cortexyme Thinks It Could Be Next In The Mega Alzheimer's Drug Market The next donnybrook in Alzheimer's disease is looming. Biogen (BIIB) gained the first approval for a treatment in June, and a slew of biotech stocks are now lining up to take on the debilitating ailment. Among them is a tiny biotech called Cortexyme (CRTX). This week's stories Just 185 Employees Or Less Generate $1 Billion At 12 Companies Trump SPAC Soars For A Second Day, But Experts Raise These Questions About The Deal' Google Partner Epam Near Buy As Fintech, Neobanks Alter Financial Landscape Gen Xers Get Final Shot At $1.01 Million Backdoor IRA Loophole Video Highlight Investing Strategies: 2021 Market Insights, Earnings Season Tactics, NFTs Explained In the Spotlight IBD’s Fang-tastic Halloween Sale! Now through Halloween, get a scary good deal on IBD Digital + Print: only $10.31 for 2 months! Free IBD Trading Summit Attend a Trading Summit in your area to learn about IBD's Investing System and the best growth stocks! Save Big on SwingTrader! Ready to start swing trading? Try 6 weeks of SwingTrader for only $39—that's $64 off! Not a member? Try this limited offer! Try 2 months of IBD Digital for only $20 UNSUBSCRIBE | MANAGE SUBSCRIPTION | PRIVACY | TERMS Sent to: stevenmagallanes520.nims@blogger.com Investor's Business Daily, LLC, PO Box 92042, Los Angeles, CA 90009 | Copyright 2021 Need help? Have feedback? Feel free to contact us ID: 7133